News & Updates
Filter by Specialty:
Novel drug STRIDES in the right direction for knee OA
21 Jun 2023
byAudrey Abella
In the phase III STRIDES X-Ray Extension study, additional doses of the investigational CLK/DYRK inhibitor lorecivivint delivered favourable outcomes for individuals with advanced knee osteoarthritis (OA).